US approves new drug for prevention of migraines
![](https://familymednews.com/wp-content/uploads/sites/15/2018/05/migraine-667x280.jpg)
Migraine sufferers on Thursday got some relief from US regulators who approved the first of a new class of drugs for migraine prevention. The United States Food and Drug Administration said it endorsed Aimovig for prevention of migraine in adults, through monthly self-injections. Aimovig is the first in a new class of drugs that work by blocking the activity of […]
Continue reading »